Co-Diagnostics, Inc. Company Description: Founded in 2013 on the principle of making affordable PCR tests available worldwide, Co-Dx™ is a molecular diagnostics provider with unique, patented technology which enables the design of high performing, cost-effective PCR for infectious diseases, at-home/point-of-care, SNP detection, vector surveillance, liquid biopsy and more. Visit us at the 5th Annual Infectious Diseases and Molecular Diagnostic Conference to see how were making our revolutionary Co-Primer™ technology available around the world.
LumiraDx is transforming healthcare with fast, accurate and comprehensive diagnostics at the point of need. With the LumiraDx Platform, and Fast Lab Solutions unit, LumiraDx supports diagnostic needs across settings; from the lab, to hospitals, the physician’s office, the workplace, and schools. Founded in 2014, LumiraDx is based in the UK with R&D and manufacturing sites across the US and Europe.
AusDiagnostics is a manufacturer and supplier of highly multiplexed, automated molecular assays for the detection of pathogens and antibiotic resistance markers (respiratory including Sars-Cov 2, enteric, STIs, HPV etc) from a wide range of clinical samples.
Key advantages of our approach are low cost, ease of use and a unique MT-PCR process that preserves the quantitative relationship between pathogens in the original sample. Our system is coupled with easy to use software and we can supply equipment and IVD kits for laboratories of all sizes.
Our mission is to develop high-performance Affimer®-based diagnostics to improve health outcomes.
Utilising our proprietary Affimer® platform we are developing an in-house pipeline of IVD tests, starting with the AffiDX® SARS-CoV-2 Antigen Lateral Flow Test. The Affimer® platform is an alternative to antibodies derived from a small human protein.
We also work with IVD companies world-wide to improve the clinical utility of diagnostic testing solutions, by combining bespoke Affimer® reagents with leading diagnostic platform technologies.
A global leader of IVD for more than 50 years, bioMérieux continues to play a pioneering role by providing high medical value diagnostics to aid clinical decisions. BioFire® FilmArray® is our innovative rapid syndromic diagnostic solution for Meningitis/Encephalitis, Respiratory and Gastrointestinal disease and Blood stream Infections. With comprehensive results provided in around an hour, BioFire testing assists with patient management decisions in a clinically relevant time-frame.
Veracyte is a pioneering, global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions. Our growing menu of advanced diagnostic tests help patients avoid risky, costly procedures and interventions, and accelerate time to appropriate treatment. Veracyte offers customized multi-omics tools and expertise to our biopharmaceutical partners, helping them advance their therapeutic discovery, development and commercialization programs.
Our vision is to reduce illness and death associated with fungal disease globally; through use of rapid diagnostic testing and targeted, appropriate use of antimicrobials. Our novel and reliable rapid-diagnostic tests fit seamlessly into current treatment pathways, with the aim of reducing the rate of drug resistant infections by promoting a new diagnostic led approach. We aim to achieve this whilst delivering clear financial and clinical benefits to hospitals, clinicians and patient care.
miDiagnostics is a medical devices company active in the development of a new generation diagnostic platform for point-of-care testing based on disruptive nano-fluidic semi-conductor technology. The technology platform has the potential to miniaturize and simplify the diagnostics process, leading to a significant cost reduction and hence enabling true point-of-care diagnostics. The company succeeded in the development of a rapid PCR test for SARS-CoV-2, providing PCR accuracy whilst being as fast as rapid antigen tests.
At Novacyt Group, we pride ourselves in concentrating our expertise on specific market needs, offering a comprehensive portfolio of quality products, backed by proven supply and delivery services, to ensure the highest possible standards of customer service around the world. Our passion is for customer-centric solutions that advance the science behind diagnostics. This fuels our drive to deliver products that save lives and help in the fight against infectious disease.
Find out more at www.novacyt.com
QuantuMDx is passionate about empowering the world to control disease and reduce suffering.
QuantuMDx solves real-world diagnostic problems by creating multiplex molecular solutions for the Point of Need, for anyone, anywhere.
Q-POC™ is a rapid, simple to use, portable, sample to answer multiplex PCR device. It’s been designed for use in a range of real-world settings, including hospitals, clinics, pharmacies, dentistry, workplaces and in the field, providing accurate PCR results at the Point of Need.
Pro-Lab Diagnostics are pleased to support the 5th Annual Infectious Diseases and Molecular Diagnostics Congress. We will have details of our extensive range of Viasure Molecular products and associated automation, and of course our range of rapid diagnostic kits and reagents for Microbiology. We look forward to seeing you there.
